Drug approved for late-stage cervical cancer.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D017277:Drug Approval; D005260:Female; D006801:Humans; D019772:Topotecan / Q000008:administration & dosage; D014481:United States; D014486:United States Food and Drug Administration; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D019772:Topotecan; D002945:Cisplatin